Background: The purpose of our study is to determine the prevalence of dyselectrolytemia in people with type 2 diabetes. Patients with diabetes frequently experience electrolyte imbalances, which may raise their risk of morbidity and mortality. Complex pharmacological regimens may be given to DM patients, some of which may be linked to electrolyte abnormalities. To minimize electrolyte problems in diabetic patients, it is crucial to stop using these medications whenever possible and maintain strict glycemic control. Objectives: The main objectives include
● To Estimate the number of patients with type 2 DM having dyselectrolytemia.
● To determine the attributed cause of dyselectrolytemia in type 2 DM patients.
● To evaluate the comorbidities and to check if it is associated for causing dyselectrolytemia.
● To study the anti-diabetic drugs taken by type 2 DM patients and to determine if it is attributing to dyselectrolytemia.
Results: One hundred and fifty inpatients and fifty outpatients with type 2 diabetes mellitus were analysed for the presence of dyselectrolytemia. Most of the patients were over the age of 50 and had comorbidities such as hypertension, CAD, and CKD. The electrolyte levels were evaluated, and hyperkalemia and hyponatremia were found to be the most common among inpatients, while hyponatremia was most common in Outpatients.
Conclusion: To conclude it is clearly seen from the results that the majority of the type 2 DM patients were significantly found to have Dyselectrolytemia. And it is observed that Biguanides and insulin were the most commonly used antidiabetic drugs and many patients also used a combination of antidiabetic with other drugs such as diuretics, and antihypertensives.
